Source link : https://www.newshealth.biz/health-news/no-psa-recurrence-at-24-months-with-apalutamide-plus-adt-after-radical-prostatectomy/
SAN ANTONIO — More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen deprivation therapy (ADT), according to a single-arm, phase II study. Two unconfirmed recurrences occurred at 24 and 30 months. Including those cases resulted in a 24-month biochemical recurrence-free […]
Author : News Health
Publish date : 2024-05-05 14:00:00
Copyright for syndicated content belongs to the linked Source.